What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2022-06-10 compared with 2022-03-11 · 16 added, 39 removed, 6 unchanged (90% of the section changed)

Other Information.

March 10, 2022, the compensation committee (the “Committee”) of the Board of Directors of the Company approved compensation

packages for each of Dr.

Amit Kumar, the President, Chief Executive Officer and Chairman of the Board of Directors of the Company, and

Michael Catelani, the Chief Operating Officer and Chief Financial Officer of the Company.

Kumar’s base salary will be increased

to $640,295 per year and he will receive a cash bonus of $200,000 and Mr.

Catelani’s base salary will be increased to $384,611

per year and he will receive a cash bonus of $50,000.

The cash bonuses earned by each of Dr.

Kumar and Mr.

Catelani are in addition to

cash bonuses of $200,000 and $100,000, respectively, approved by the Committee and received by Dr.

Kumar and Mr.

Catelani in January

In addition, Dr.

Kumar and Mr.

Catelani each received a stock option to purchase 500,000 shares of the Company’s common stock

pursuant to the 2018 Share Plan.

The stock options are exercisable at an exercise price of $2.74 per share (the closing price of the

Common Stock on the Nasdaq Capital Market on March 10, 2022), have a 10 year term and vest on a monthly basis over three years beginning

on March 31, 2022.

If either Dr.

Catelani is terminated for any reason, the stock option will cease vesting, and they will

have five (5) years to exercise the vested portion of such grant.

Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated March 11, 2022.

Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated March 11, 2022.

Statement of Chief Executive Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated March 11, 2022.

Statement of Chief Financial Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated March 11, 2022.

XBRL Instance Document

XBRL Taxonomy Extension Schema Document

XBRL Taxonomy Extension Calculation Linkbase Document

XBRL Taxonomy Extension Definition Linkbase Document

XBRL Taxonomy Extension Label Linkbase Document

XBRL Taxonomy Extension Presentation Linkbase Document

Page Interactive Data File (embedded within the Inline XBRL document)

Certification

of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated June 10, 2022.

Certification

of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated June 10, 2022.

of Chief Executive Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated June 10, 2022.

of Chief Financial Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated June 10, 2022.

Inline XBRL Instance Document

Inline XBRL Taxonomy Extension Schema

Inline XBRL Taxonomy Extension Calculation Linkbase

Inline XBRL Taxonomy Extension Definition Linkbase

Inline XBRL Taxonomy Extension Label Linkbase

Inline XBRL Taxonomy Extension Presentation Linkbase

Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by

1 unchanged sentence

BIOSCIENCES, INC.

President and

Executive Officer

and Chief Executive Officer

Executive Officer)

Operating Officer and

Chief Operating Officer and

Financial Officer

Financial and

Financial and Accounting Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information